Vismodegibfor the treatment of radiation-induced basal cell carcinoma – a case report and brief literature study

Vismodegib is playing an increasing role in the treatment of locally advanced or metastatic basal cell carcinoma (BCC) that is not a candidate for surgery or radiotherapy, and also in radiation-induced BCC. A 22-year-old man with a history of Hodgkin lymphoma, nodular sclerosis stage IIA, from Octob...

Descripción completa

Detalles Bibliográficos
Autores principales: Laliscia, Concetta, Baldaccini, Davide, Antonuzzo, Andrea, Paiar, Fabiola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978755/
https://www.ncbi.nlm.nih.gov/pubmed/31992959
http://dx.doi.org/10.5114/wo.2019.91540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978755/
https://www.ncbi.nlm.nih.gov/pubmed/31992959
http://dx.doi.org/10.5114/wo.2019.91540

Ejemplares similares